ClinicalThought™
Interact with experts and peers.

Recent Posts

1 of 1 Shown
  • Liraglutide in Diabetes: Cardiovascular Implications of the LEADER Trial

    Vivian A. Fonseca MD, FRCP - 8/15/2016 2 comments / Last Comment: 2/28/2017
    Join Vivian A. Fonesca, MD, FRCP, as he shares his thoughts on the results of the phase III LEADER trial, which demonstrated a cardiovascular benefit for liraglutide in patients with type 2 diabetes who have cardiovascular disease.
1 of 1 Shown
Show 0 More
Loading...